<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36748919</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-2707</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical pediatrics</Title><ISOAbbreviation>Clin Pediatr (Phila)</ISOAbbreviation></Journal><ArticleTitle>Comparison of Symptom Duration Between Children With SARS-CoV-2 and Peers With Other Viral Illnesses During the COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>1101</StartPage><EndPage>1108</EndPage><MedlinePgn>1101-1108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00099228231152840</ELocationID><Abstract><AbstractText>Some children and young people (CYP) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience persistent symptoms, commonly called "long COVID." It remains unclear whether symptoms of SARS-CoV-2 persist longer than those of other respiratory viruses, particularly in young children. This cross-sectional study involved 372 CYP (0-15 years) tested for SARS-CoV-2. Character and duration of symptoms (cough, runny nose, sore throat, rash, diarrhea, vomiting, sore muscles, fatigue, fever, loss of smell) were compared between CYP with a positive test (n = 100) and those with a negative test (n = 272), while controlling for medical/demographic covariates. The average duration of symptoms for CYP with a positive SARS-CoV-2 test (8.5 &#xb1; 10 days) did not differ from that of CYP with a negative test (7.2 &#xb1; 5 days, <i>P</i> = .71, d = 0.046). A positive SARS-CoV-2 test did not increase the risk (36/372, 10%) of symptoms persisting for &#x2265;3 weeks (odds ratio = 0.96, 95% confidence interval = 0.45-2.0). These results suggest CYP with non-SARS-CoV-2 infections experience a similar duration of symptoms as peers with SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hicks</LastName><ForeName>Steven D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-9579-6798</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R61 HD105610</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Pediatr (Phila)</MedlineTA><NlmUniqueID>0372606</NlmUniqueID><ISSNLinking>0009-9228</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general pediatrics</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword></KeywordList><CoiStatement>The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The author serves as a paid consultant and scientific advisory board member for Quadrant Biosciences and Spectrum Solutions, neither of whom played a role in the current study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>8</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36748919</ArticleId><ArticleId IdType="pmc">PMC9908512</ArticleId><ArticleId IdType="doi">10.1177/00099228231152840</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mehta NS, Mytton OT, Mullins EWS, et al.. SARS-CoV-2 (COVID-19): what do we know about children? a systematic review. Clin Infect Dis. 2020;71(9):2469-2479. doi:10.1093/cid/ciaa556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa556.</ArticleId><ArticleId IdType="pmc">PMC7239259</ArticleId><ArticleId IdType="pubmed">32392337</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi:10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648.</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brand&#xe3;o MB. Clinical manifestations of children with COVID-19: a systematic review. Pediatr Pulmonol. 2020;55(8):1892-1899. doi:10.1002/ppul.24885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24885.</ArticleId><ArticleId IdType="pmc">PMC7300659</ArticleId><ArticleId IdType="pubmed">32492251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482-e487. doi:10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328.</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: an updated review. Pediatr Infect Dis J. 2022;41(5):424-426. doi:10.1097/INF.0000000000003502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003502.</ArticleId><ArticleId IdType="pmc">PMC8997013</ArticleId><ArticleId IdType="pubmed">35213866</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V, Meoli A, Chiopris G, et al.. Long COVID in children and adolescents. Life (Basel). 2022;12(2):285. doi:10.3390/life12020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285.</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J, et al.. Comparison of metnal health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep. 2022;12(1):1-8. doi:10.1038/s41598-022-06166-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al.. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708-718. doi:10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X.</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F, Nguyen V, Navaratnam AMD, et al.. Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales [published online ahead of print June 2, 2021]. medRxiv. doi:10.1101/2021.05.28.21257602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.21257602.</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al.. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open. 2021;11(8):e052838. doi:10.1136/bmjopen-2021-052838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838.</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira L&#xf3;pez J, Grasa C, Calvo C, Garc&#xed;a L&#xf3;pez-Hortelano M. Long-term symptoms of COVID-19 in children. Acta Paediatr. 2021;110(7):2282-2283. doi:10.1111/apa.15849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15849.</ArticleId><ArticleId IdType="pmc">PMC8251185</ArticleId><ArticleId IdType="pubmed">33745209</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E, Olsson-&#xc5;kefeldt S, Hertting O, et al.. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110(9):2578-2580. doi:10.1111/apa.15999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15999.</ArticleId><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al.. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607-1613. doi:10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3.</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al.. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208-2211. doi:10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870.</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, et al.. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495-499. doi:10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6.</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326(9):869-871. doi:10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880.</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachman B. Counseling the patient with cold/flu symptoms. Am Pharm. 1987; NS27(9):51-54. doi:10.1016/s0160-3450(16)33319-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0160-3450(16)33319-0.</ArticleId><ArticleId IdType="pubmed">2447769</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrino AS, Santos R, Melo C, Bastos JM, Postiaux G. Caregivers&#x2019; education vs rhinopharyngeal clearance in children with upper respiratory infections: impact on children&#x2019;s health outcomes. Eur J Pediatr. 2017;176(10):1375-1383. doi:10.1007/s00431-017-3003-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-017-3003-z.</ArticleId><ArticleId IdType="pubmed">28849302</ArticleId></ArticleIdList></Reference><Reference><Citation>
Vahratian A. Long COVID content in the National Health Interview Survey &amp; the Household Pulse Survey. Published 2022. Accessed January 18, 2023. https://www.cdc.gov/nchs/data/bsc/bsc-pres-anjel-vahratian-nhis-pulse-survey-10-24-2022.pdf.</Citation></Reference><Reference><Citation>Ho CL, Oligbu P, Ojubolamo O, Pervaiz M, Oligbu G. Clinical characteristics of children with COVID-19. AIMS Public Health. 2020;7(2):258-273. doi:10.1002/ppul.24991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24991.</ArticleId><ArticleId IdType="pmc">PMC7327402</ArticleId><ArticleId IdType="pubmed">32617354</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Vodicka TA, Blair PS, et al.. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027. doi:10.1136/bmj.f7027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f7027.</ArticleId><ArticleId IdType="pmc">PMC3898587</ArticleId><ArticleId IdType="pubmed">24335668</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink TT, Marques HHS, Gualano B, et al.. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: a prospective study in a Latin American tertiary hospital. Clinics (Sao Paulo). 2021;76:e3511. doi:10.6061/clinics/2021/e3511.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e3511.</ArticleId><ArticleId IdType="pmc">PMC8595593</ArticleId><ArticleId IdType="pubmed">34852145</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, Smane L, Kivite-Urtane A, et al.. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr. 2021;9:752385. doi:10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385.</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M, Ireland G, Amin-Chowdhury Z, et al.. Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance. Clin Infect Dis. 2022;75:e191-e200. doi:10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991.</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, et al.. Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 [published online ahead of print October 22, 2021]. medRxiv. doi:10.1101/2021.10.21.21265133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133.</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsankov BK, Allaire JM, Irvine MA, et al.. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis. 2021;103:246-256. doi:10.1016/j.ijid.2020.11.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.163.</ArticleId><ArticleId IdType="pmc">PMC7679116</ArticleId><ArticleId IdType="pubmed">33227520</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al.. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597-1607. doi:10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z.</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>